Physician profile
Michael Patrick Abner
NPI 1972020451
$28,021.37
in general payments reported to CMS, 2019-2025
13 companies · $8,090 in 2025
The $8,090 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $168 · 2022: $1,515 · 2023: $6,455 · 2024: $12K · 2025: $8,090.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Food and Beverage: $7,359 · Travel and Lodging: $4,254 · Consulting Fee: $1,570.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13,155.00 |
| Food and Beverage | $7,358.61 |
| Travel and Lodging | $4,254.29 |
| Consulting Fee | $1,570.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $24,569.70 | 2021-2025 | Descovy, Yeztugo, Biktarvy |
| Viiv Healthcare Company | $1,906.01 | 2022-2025 | Dovato, Apretude, Cabenuva |
| Theratechnologies INC. | $509.12 | 2022-2025 | Trogarzo, Egrifta |
| Merck Sharp & Dohme LLC | $348.06 | 2023-2025 | Pifeltro, Delstrigo, Capvaxive |
| Abbvie INC. | $298.79 | 2022-2024 | Mavyret, Ubrelvy |
| Janssen Products, Lp | $124.55 | 2022 | |
| Exact Sciences Corporation | $62.70 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $62.17 | 2024-2025 | |
| Organon LLC | $39.00 | 2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $38.11 | 2022 | |
| Emd Serono, INC. | $26.89 | 2024 | |
| Janssen Scientific Affairs, LLC | $19.52 | 2023 | Symtuza |
| Hologic Sales and Service, LLC | $16.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Abner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.